Healthy Aging in People With Epilepsy Program

This study is testing an educational program called "Healthy Aging in People with Epilepsy Program" for people aged 55 to 90 who have epilepsy. The program is a 12-week group class that teaches about healthy aging, managing long-term health problems, dementia (a decline in memory and thinking skills), and lifestyle changes that can reduce dementia risk. The main goal is to see if this education can improve your knowledge about dementia and aging, and potentially improve your quality of life. You'll be asked to complete surveys before and after the program to help researchers understand how well it works and any challenges you face in getting care.

Study design
This is an interventional study planning to enroll 380 participants. Participants will be randomly assigned to either receive the educational program or be in a control group.
What's involved
If you are in the intervention group, you will complete a 12-week group educational program. Both groups will complete evaluations before and after the program.
Compensation
Not stated in the trial record.
Follow-up
Your dementia knowledge, program acceptability, and satisfaction will be measured at 3 months after the program ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06052605

Healthy Aging in People With Epilepsy Program

Recruiting
NAAges 55–90InterventionalSupportive care
Anny Reyes
~380 participants
Updated 2026-06-12 on ClinicalTrials.gov
What's tested:Healthy Aging in People with Epilepsy ProgramPatient SurveyProvider Survey

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Dementia Knowledge
Measured over Baseline (Week 0) and post-intervention (Month 3)
+4 more outcomes measured
Epilepsy
1 sites across 1 states
Ohio1
  • Anny Reyes, PhD · PRINCIPAL_INVESTIGATOR · The Cleveland Clinic

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Part 1a - Patient Survey:
Current diagnosis of epilepsy made by a neurologist, epileptologist, or internist/family medicine physician
Age 55 years or older
Proficiency in English (self-assessed)
Part 1b - Provider Survey:
Healthcare professional in the US who is involved in the clinical care or treatment of individuals with epilepsy (including Epilepsy Foundation organizational leaders)
Part 3:
Current diagnosis of epilepsy made by a neurologist, epileptologist, or internist/family medicine physician
Age 55 years or older (up to 90)
Proficiency in English (self-assessed)

Exclusion

Part 1a:
Evidence of Dementia (based on phone cognitive screener; those with suspected mild cognitive impairment will not be excluded)
Age 90 years or older
Part 3:
Evidence of Dementia (based on phone cognitive screener; those with suspected mild cognitive impairment will not be excluded)
Age 90 years or older
  • Dementia KnowledgeBaseline (Week 0) and post-intervention (Month 3)

    Dementia Knowledge Assessment Tool was designed to measure change in knowledge of dementia including dementia and its progress, support, and care. It contains 21 true/false items (higher score indicates greater dementia knowledge).

  • Acceptability of Study ProgramPost-intervention (Month 3)

    Defined by participation rate of 80% or greater in intervention (higher number indicates greater acceptability of the program)

  • Program SatisfactionPost-intervention (Month 3)

    As assessed by Client Satisfaction Questionnaire (Min-Max 8-32, higher number is greater satisfaction)

  • Epilepsy Self-ManagementBaseline (Week 0) and post-intervention (Month 3)

    Use of epilepsy self-management practices will be assessed with the Epilepsy Self-Management Scale (Min-Max 38-190, higher score means more frequent use of self-management strategies).

  • Attitudes about AgingBaseline (Week 0) and post-intervention (Month 3)

    As measured by the Attitudes about Aging questionnaire (3 subscales with Min-Max 8-40; for two subscales, higher score mean more positive attitude; and for the third subscale, higher score means more negative attitude)